HAX is a venture capital program focused on accelerating hardware startups, operating from San Francisco and Shenzhen. Established in 2012, HAX provides founders with essential resources to rapidly prototype and iterate their products, encompassing physical models, technology developments, user interaction studies, and comprehensive business plans. The program supports accepted teams through a combination of full-time staff, mentors, and a vibrant startup community, emphasizing the development of scalable business strategies. Once products are ready for market introduction, teams transition to San Francisco, where HAX assists with business development, fundraising, and establishing critical partnerships. The program includes specialized initiatives such as HAX Growth, a 7-week bootcamp for launching B2C and B2B hardware startups, and HAX Boost, which helps teams refine their sales and marketing strategies while preparing for growth. HAX is part of SOSV, a global venture capital firm with a diverse portfolio, focusing on technology startups that aim to create meaningful innovations.
Vision IV develops, produces diamond integrated anvil to evaluate, change and synthesize the properties of susbstances under high pressure.
InnSight Technology
Seed Round in 2025
InnSight Technology is a biotechnology company focused on enhancing diagnostics and evaluation of eye diseases. The company develops innovative ophthalmic devices, including a novel hand-held biosensor designed for the detection of anterior ophthalmic injuries. Additionally, InnSight Technology works on advanced nanotechnology-based medical devices aimed at addressing specific clinical needs in ophthalmology. By providing these tools, the company seeks to improve ocular care for clinicians and their patients.
Sharper Sense
Seed Round in 2025
Sharper Sense is a company focused on wearable neurotechnology designed to enhance sensory acuity, including vision, hearing, and touch. The firm has developed a neuromodulation patch that employs comfortable, noninvasive electrical stimulation to improve sensory processing. This technology has both clinical and commercial applications, particularly in treating sensory processing disorders and sensory loss. By enhancing performance and safety, Sharper Sense aims to provide users with a clearer and more accurate perception of their surroundings.
Macheon AI
Seed Round in 2024
Macheon AI is a robotics company that manufactures surgical robots for head and neck surgery that provide AI-driven decision support.
OLI
Seed Round in 2024
Medical Devices, Kidney Disease, Wearables, Medtech, Hardtech
Bloomlife
Series B in 2024
Bloomlife is a women's health company focused on addressing critical challenges in maternal health through an innovative remote care platform. By integrating connected devices with cloud-based data analytics, Bloomlife enhances access to care and empowers expectant mothers while providing clinicians with essential information to better screen and manage pregnancy complications. The company's prenatal wearable technology is designed to assess fetal health, enabling the identification of potential complications that could lead to serious outcomes such as brain damage or stillbirth. This approach marks a significant departure from traditional methods of managing high-risk pregnancies, which often involve frequent in-person appointments and lengthy referral processes. Bloomlife aims to be a leader in remote maternal care, facilitating timely interventions and support for women, regardless of geographic barriers.
Medical Devices Corner
Pre Seed Round in 2024
Medical Devices Corner is a company focused on developing innovative medical devices aimed at enhancing cancer diagnosis and treatment. Their primary offering is a novel robotic system designed to facilitate minimally invasive surgeries. By advancing device technology, the company supports healthcare professionals in performing procedures that include biopsies and ablations with reduced invasiveness. Through its commitment to improving surgical techniques, Medical Devices Corner plays a crucial role in the health industry, striving to enhance patient outcomes and streamline medical processes.
ZiO Health
Convertible Note in 2024
ZiO Health is a biotechnology company that focuses on transforming laboratory testing through its proprietary pocket-sized technology, which allows for point-of-care diagnostics. By combining advanced biosensor technology with machine learning algorithms, ZiO Health provides real-time testing results tailored to each patient's unique profile. This innovative approach enables users to measure, test, and detect the molecular composition of various substances, facilitating personalized health insights. The company's devices aim to optimize health management and enhance patient outcomes, allowing individuals to conduct quality home diagnostics and take proactive steps in preventing illness.
Zhenshi Medical
Convertible Note in 2024
Zhenshi Medical is a medical device company that specializes in lung puncture medical robots for diagnosing and treating lung cancer.
DeepSpin
Convertible Note in 2024
DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.
kegg
Series A in 2024
Kegg is a fertility tracking device that combines the functions of monitoring vaginal fluid and facilitating pelvic floor exercises. Founded in 2017 and based in San Francisco, California, Kegg utilizes advanced sensing technology to detect changes in cervical fluid, thereby enabling women to identify their fertile window and ovulation up to seven days in advance. This innovative approach provides essential data that enhances the diagnosis, monitoring, and treatment of women's reproductive health, significantly increasing the chances of natural conception. By offering an intuitive and effective solution, Kegg empowers women with the information they need to make informed decisions regarding their fertility.
3DK Tech
Seed Round in 2023
3DK Tech, located at HAX, specializes in advanced metal 3D printing technology aimed at enhancing manufacturing processes for various industries, including aerospace, medical, and automotive. The company has developed a proprietary method that improves the selective laser melting (SLM) process, allowing for the production of complex parts with exceptional precision and efficiency. This innovation offers significant advantages, delivering parts that are 200 times more durable, produced 10 times faster, and at a cost 10 times more effective than traditional manufacturing methods. By focusing on aviation maintenance, repair, and operations (MRO), 3DK Tech provides businesses with the ability to create high-quality components that meet rigorous industry standards.
OLI
Seed Round in 2023
Medical Devices, Kidney Disease, Wearables, Medtech, Hardtech
Feel Therapeutics
Convertible Note in 2023
Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.
Artyc
Series A in 2023
Artyc specializes in providing sustainable cold shipping solutions for the biotech, pharmaceutical, and medical sectors. The company manufactures refrigerant-free, reusable, active cooling containers designed to decarbonize the cold chain, thereby fostering a more sustainable logistics industry. By utilizing these innovative containers, businesses can benefit from reduced shipping costs and enhanced temperature monitoring throughout their logistics operations, ensuring the safe and efficient transport of temperature-sensitive goods.
Optimize Health
Series B in 2023
Optimize Health is a digital healthcare provider specializing in remote patient monitoring (RPM) solutions. The company offers a user-friendly platform that incorporates both equipment and software designed to streamline the implementation of RPM programs. Its software aids healthcare providers in complying with Medicare billing requirements for RPM services while ensuring a positive experience for both patients and providers. The platform automatically tracks medication doses and sends reminders to users, leveraging Bluetooth technology to sync with smartphones and tablets. This approach empowers patients to manage their health effectively and enables physicians to achieve profitability from RPM services starting in the first month.
Medical Devices Corner
Convertible Note in 2023
Medical Devices Corner is a company focused on developing innovative medical devices aimed at enhancing cancer diagnosis and treatment. Their primary offering is a novel robotic system designed to facilitate minimally invasive surgeries. By advancing device technology, the company supports healthcare professionals in performing procedures that include biopsies and ablations with reduced invasiveness. Through its commitment to improving surgical techniques, Medical Devices Corner plays a crucial role in the health industry, striving to enhance patient outcomes and streamline medical processes.
DIA
Grant in 2023
Dia has invented an electrochemical sensor that can measure a wide variety of chemical biomarkers non-invasively in saliva or sweat. The data is sent via Bluetooth to an app on the user’s smartphone and analyzed in real-time. From the app, it can be securely sent to a third party. To date, we have measured hormones, electrolytes, neurotransmitters and metabolites. At DIA, we let the biology dictate which analyte we put on which platform – our wearable arm sleeve for sweat or our table-top device for saliva – because some biomarkers, such as cortisol fluctuate throughout the day and need to be monitored through a wearable sensor, while others, such as creatinine are more suitable to a daily saliva test.
Japet
Convertible Note in 2023
Japet Medical Devices is a French biomedical company focused on developing innovative robotic equipment aimed at enhancing treatment quality. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to assist with both occupational and daily health needs. These exoskeletons are designed to restore balance and facilitate free movement, offering pain relief through orthotic support. Japet's commitment to creating user-friendly solutions reflects its belief in the transformative potential of these technologies to improve the quality of life for many individuals.
Kinexcs
Convertible Note in 2022
Kinexcs is an AI-driven health platform and wearables company focused on enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. It addresses issues of incomplete recovery and patient compliance through its innovative digital therapy solutions, which are both cost-effective and convenient. The company has developed KIMIA, the world's first continuous knee health monitor, combined with an AI-based digital therapist that facilitates access to therapy. Kinexcs collaborates with key opinion leaders and major public hospitals in Singapore on various clinical projects, while also offering its products through orthopedic surgeons and significant implant manufacturers. The integration of continuous monitoring and real-time exercise guidance supports patients in managing their conditions effectively.
FluidAI
Seed Round in 2022
FluidAI Medical is a company dedicated to enhancing patient care through innovative technology in post-operative recovery. It has developed a smart catheter system that employs artificial intelligence to monitor patients' health data within the body. This proactive approach enables the early detection of postoperative complications, allowing healthcare providers to access critical health information promptly. By leveraging data-driven insights, FluidAI aims to improve recovery outcomes and transform the standards of post-operative care.
Artyc
Seed Round in 2022
Artyc specializes in providing sustainable cold shipping solutions for the biotech, pharmaceutical, and medical sectors. The company manufactures refrigerant-free, reusable, active cooling containers designed to decarbonize the cold chain, thereby fostering a more sustainable logistics industry. By utilizing these innovative containers, businesses can benefit from reduced shipping costs and enhanced temperature monitoring throughout their logistics operations, ensuring the safe and efficient transport of temperature-sensitive goods.
Portable Diagnostic Systems
Seed Round in 2022
Portable Diagnostic Systems develops a microfluidics-based drug testing platform for law enforcement that takes the guesswork out of impaired driving traffic stops. The company was founded in August 2019.
Zennea Technologies
Convertible Note in 2022
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet wearable designed to address chronic snoring and mild obstructive sleep apnea at its source. Zennea conducts clinical trials to validate the effectiveness of its technology, which not only targets snoring but also tracks sleep quality, assisting users in making informed decisions to enhance their sleep health.
Harae Dx
Convertible Note in 2022
Harae Dx Corp. is a medical diagnostics company specializing in cancer detection. The company has created an automated, portable system that facilitates early cancer diagnosis by identifying cancer biomarkers directly, eliminating the need to send samples to third-party laboratories. This innovative approach reduces the risk of human error in processing and enhances the speed of results, allowing healthcare professionals to detect and treat cancer more effectively and affordably. Harae Dx's compact and cost-efficient solution aims to improve patient outcomes through timely and accurate diagnostics.
Leadoptik
Angel Round in 2022
Leadoptik is a deep-tech company focused on developing advanced miniature imaging technology designed for minimally invasive medical procedures. Its platform enhances surgical capabilities by providing high-resolution imaging and 3D navigation in real time, allowing surgeons to visualize small anatomical structures with greater clarity than existing imaging systems. This innovative approach facilitates the early detection of cancer and improves the overall effectiveness of surgical interventions, ultimately contributing to better patient outcomes.
Criam
Seed Round in 2021
Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.
Harae Dx
Seed Round in 2021
Harae Dx Corp. is a medical diagnostics company specializing in cancer detection. The company has created an automated, portable system that facilitates early cancer diagnosis by identifying cancer biomarkers directly, eliminating the need to send samples to third-party laboratories. This innovative approach reduces the risk of human error in processing and enhances the speed of results, allowing healthcare professionals to detect and treat cancer more effectively and affordably. Harae Dx's compact and cost-efficient solution aims to improve patient outcomes through timely and accurate diagnostics.
DeepSpin
Convertible Note in 2021
DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.
Medical Devices Corner
Seed Round in 2021
Medical Devices Corner is a company focused on developing innovative medical devices aimed at enhancing cancer diagnosis and treatment. Their primary offering is a novel robotic system designed to facilitate minimally invasive surgeries. By advancing device technology, the company supports healthcare professionals in performing procedures that include biopsies and ablations with reduced invasiveness. Through its commitment to improving surgical techniques, Medical Devices Corner plays a crucial role in the health industry, striving to enhance patient outcomes and streamline medical processes.
Leadoptik
Seed Round in 2020
Leadoptik is a deep-tech company focused on developing advanced miniature imaging technology designed for minimally invasive medical procedures. Its platform enhances surgical capabilities by providing high-resolution imaging and 3D navigation in real time, allowing surgeons to visualize small anatomical structures with greater clarity than existing imaging systems. This innovative approach facilitates the early detection of cancer and improves the overall effectiveness of surgical interventions, ultimately contributing to better patient outcomes.
kegg
Convertible Note in 2020
Kegg is a fertility tracking device that combines the functions of monitoring vaginal fluid and facilitating pelvic floor exercises. Founded in 2017 and based in San Francisco, California, Kegg utilizes advanced sensing technology to detect changes in cervical fluid, thereby enabling women to identify their fertile window and ovulation up to seven days in advance. This innovative approach provides essential data that enhances the diagnosis, monitoring, and treatment of women's reproductive health, significantly increasing the chances of natural conception. By offering an intuitive and effective solution, Kegg empowers women with the information they need to make informed decisions regarding their fertility.
Elephant Robotics
Convertible Note in 2020
Elephant Robotics specializes in the development of cooperative robots designed to assist users with repetitive tasks across various industries, including medical, education, agriculture, scientific research, and transportation. Their robots feature integrated arm, voice, and vision systems, which facilitate applications such as pick and place, packaging, and testing. By offering user-friendly automation solutions, Elephant Robotics enables businesses to enhance productivity while ensuring a safe working environment and reducing production costs. The company is recognized for providing innovative, OS-based applications and intelligent manufacturing services, aiming to improve daily life through the integration of advanced robotic technology.
Sepsitron
Pre Seed Round in 2020
Sepsitron specializes in medical diagnostic technology that enables the rapid detection of blood infections caused by various pathogens, including viral, bacterial, parasitic, and fungal agents. The company's innovative approach utilizes unique biomarkers, microfluidics, and advanced electronics to provide a diagnostic device that is significantly faster and more cost-effective than traditional methods. Sepsitron's tests require no sample pre-processing and can analyze whole blood samples, allowing for the precise identification of multiple pathogens from a single test. This technology aims to enhance the speed and effectiveness of disease detection and treatment for healthcare professionals. Sepsitron has garnered support from prominent startup accelerators, positioning itself as a leader in point-of-care diagnostics.
DeepSpin
Seed Round in 2020
DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.
nura
Series A in 2020
The nuraphone is a new headphone that integrates unique technology to automatically measure your hearing (from the outer ear all the way to the brain) and adapt music perfectly to you. In order for headphones to deliver the right sound, they must be matched to the listener. Nuraphones even recognize you when you put them on.
Zennea Technologies
Seed Round in 2020
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet wearable designed to address chronic snoring and mild obstructive sleep apnea at its source. Zennea conducts clinical trials to validate the effectiveness of its technology, which not only targets snoring but also tracks sleep quality, assisting users in making informed decisions to enhance their sleep health.
Babybe
Convertible Note in 2019
Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
Sepsitron
Pre Seed Round in 2019
Sepsitron specializes in medical diagnostic technology that enables the rapid detection of blood infections caused by various pathogens, including viral, bacterial, parasitic, and fungal agents. The company's innovative approach utilizes unique biomarkers, microfluidics, and advanced electronics to provide a diagnostic device that is significantly faster and more cost-effective than traditional methods. Sepsitron's tests require no sample pre-processing and can analyze whole blood samples, allowing for the precise identification of multiple pathogens from a single test. This technology aims to enhance the speed and effectiveness of disease detection and treatment for healthcare professionals. Sepsitron has garnered support from prominent startup accelerators, positioning itself as a leader in point-of-care diagnostics.
Feel Therapeutics
Seed Round in 2019
Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.
Seein Health
Venture Round in 2019
Seein Health is a developer of pro-pregnancy products focused on enhancing fertility and supporting maternal health. The company offers a range of products, including thermometers, menstrual test strips, and advanced physiological parameter monitoring equipment. These products aim to ensure the health and safety of pregnant mothers by providing essential tools for monitoring fertility and pregnancy status. Additionally, Seein Health provides overseas services related to test-tube baby procedures and frozen eggs, further contributing to reproductive health solutions.
Kinexcs
Seed Round in 2019
Kinexcs is an AI-driven health platform and wearables company focused on enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. It addresses issues of incomplete recovery and patient compliance through its innovative digital therapy solutions, which are both cost-effective and convenient. The company has developed KIMIA, the world's first continuous knee health monitor, combined with an AI-based digital therapist that facilitates access to therapy. Kinexcs collaborates with key opinion leaders and major public hospitals in Singapore on various clinical projects, while also offering its products through orthopedic surgeons and significant implant manufacturers. The integration of continuous monitoring and real-time exercise guidance supports patients in managing their conditions effectively.
Bravrr
Pre Seed Round in 2019
Bravrr, LLC is a company based in Canon City, Colorado, specializing in the development of wearable diagnostic and therapeutic tools. Founded in 2019, Bravrr's flagship product, BruxRelief, is a smart biofeedback wearable designed to detect, treat, and eliminate bruxism disorder, which affects approximately one in three individuals, yet remains largely undiagnosed. The BruxRelief headband utilizes advanced sensors and artificial intelligence to monitor clenching and grinding behaviors in the temporalis muscle, allowing users to identify stress triggers associated with these actions. The device connects to a smartphone app that analyzes users' bruxism behavior and sleep patterns, providing an accessible solution in a market where existing diagnostic tools are often overly complex and expensive. By offering a simple, effective means to address bruxism, Bravrr aims to improve the quality of life for those suffering from this painful condition.
Elephant Robotics
Seed Round in 2019
Elephant Robotics specializes in the development of cooperative robots designed to assist users with repetitive tasks across various industries, including medical, education, agriculture, scientific research, and transportation. Their robots feature integrated arm, voice, and vision systems, which facilitate applications such as pick and place, packaging, and testing. By offering user-friendly automation solutions, Elephant Robotics enables businesses to enhance productivity while ensuring a safe working environment and reducing production costs. The company is recognized for providing innovative, OS-based applications and intelligent manufacturing services, aiming to improve daily life through the integration of advanced robotic technology.
Zennea Technologies
Convertible Note in 2019
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet wearable designed to address chronic snoring and mild obstructive sleep apnea at its source. Zennea conducts clinical trials to validate the effectiveness of its technology, which not only targets snoring but also tracks sleep quality, assisting users in making informed decisions to enhance their sleep health.
Babybe
Convertible Note in 2018
Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
nura
Series A in 2018
The nuraphone is a new headphone that integrates unique technology to automatically measure your hearing (from the outer ear all the way to the brain) and adapt music perfectly to you. In order for headphones to deliver the right sound, they must be matched to the listener. Nuraphones even recognize you when you put them on.
Kinexcs
Seed Round in 2018
Kinexcs is an AI-driven health platform and wearables company focused on enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. It addresses issues of incomplete recovery and patient compliance through its innovative digital therapy solutions, which are both cost-effective and convenient. The company has developed KIMIA, the world's first continuous knee health monitor, combined with an AI-based digital therapist that facilitates access to therapy. Kinexcs collaborates with key opinion leaders and major public hospitals in Singapore on various clinical projects, while also offering its products through orthopedic surgeons and significant implant manufacturers. The integration of continuous monitoring and real-time exercise guidance supports patients in managing their conditions effectively.
Elephant Robotics
Seed Round in 2018
Elephant Robotics specializes in the development of cooperative robots designed to assist users with repetitive tasks across various industries, including medical, education, agriculture, scientific research, and transportation. Their robots feature integrated arm, voice, and vision systems, which facilitate applications such as pick and place, packaging, and testing. By offering user-friendly automation solutions, Elephant Robotics enables businesses to enhance productivity while ensuring a safe working environment and reducing production costs. The company is recognized for providing innovative, OS-based applications and intelligent manufacturing services, aiming to improve daily life through the integration of advanced robotic technology.
Seein Health
Seed Round in 2018
Seein Health is a developer of pro-pregnancy products focused on enhancing fertility and supporting maternal health. The company offers a range of products, including thermometers, menstrual test strips, and advanced physiological parameter monitoring equipment. These products aim to ensure the health and safety of pregnant mothers by providing essential tools for monitoring fertility and pregnancy status. Additionally, Seein Health provides overseas services related to test-tube baby procedures and frozen eggs, further contributing to reproductive health solutions.
Babybe
Series A in 2018
Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
kegg
Convertible Note in 2018
Kegg is a fertility tracking device that combines the functions of monitoring vaginal fluid and facilitating pelvic floor exercises. Founded in 2017 and based in San Francisco, California, Kegg utilizes advanced sensing technology to detect changes in cervical fluid, thereby enabling women to identify their fertile window and ovulation up to seven days in advance. This innovative approach provides essential data that enhances the diagnosis, monitoring, and treatment of women's reproductive health, significantly increasing the chances of natural conception. By offering an intuitive and effective solution, Kegg empowers women with the information they need to make informed decisions regarding their fertility.
ZiO Health
Seed Round in 2018
ZiO Health is a biotechnology company that focuses on transforming laboratory testing through its proprietary pocket-sized technology, which allows for point-of-care diagnostics. By combining advanced biosensor technology with machine learning algorithms, ZiO Health provides real-time testing results tailored to each patient's unique profile. This innovative approach enables users to measure, test, and detect the molecular composition of various substances, facilitating personalized health insights. The company's devices aim to optimize health management and enhance patient outcomes, allowing individuals to conduct quality home diagnostics and take proactive steps in preventing illness.
Zennea Technologies
Pre Seed Round in 2018
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet wearable designed to address chronic snoring and mild obstructive sleep apnea at its source. Zennea conducts clinical trials to validate the effectiveness of its technology, which not only targets snoring but also tracks sleep quality, assisting users in making informed decisions to enhance their sleep health.
Criam
Convertible Note in 2018
Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.
Pillsy
Seed Round in 2017
Pillsy is an enterprise-grade platform for remote patient support and rapid development of connected medication experiences. It is a new smart pill bottle and app that uses behavioral science to support healthy habits around vitamins and medications. It also securely share the pill-taking information with loved ones and to help monitor people. Pillsy was founded in 2015 and is headquartered in Seattle, Washington.
Babybe
Convertible Note in 2017
Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
kegg
Seed Round in 2017
Kegg is a fertility tracking device that combines the functions of monitoring vaginal fluid and facilitating pelvic floor exercises. Founded in 2017 and based in San Francisco, California, Kegg utilizes advanced sensing technology to detect changes in cervical fluid, thereby enabling women to identify their fertile window and ovulation up to seven days in advance. This innovative approach provides essential data that enhances the diagnosis, monitoring, and treatment of women's reproductive health, significantly increasing the chances of natural conception. By offering an intuitive and effective solution, Kegg empowers women with the information they need to make informed decisions regarding their fertility.
AptaCam
Pre Seed Round in 2017
AptaCam is a biotechnology company based in Shenzhen, China, that specializes in the development of biosensors for the detection of human papillomavirus (HPV) and other infectious diseases. Founded in 2014, the company also creates software that enhances the functionality of its portable diagnostic devices by enabling data analysis and collection when connected to a computer. AptaCam aims to be a leading producer of high-quality aptamers, which are short, single-stranded molecules that can be tailored for high specificity to various targets. The company's innovative platform supports clinical diagnostics, drug discovery, and monitoring in medical, environmental, and food safety applications. Through its commitment to simplifying molecular recognition, AptaCam provides comprehensive aptamer solutions across diverse disciplines.
Kinexcs
Pre Seed Round in 2017
Kinexcs is an AI-driven health platform and wearables company focused on enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. It addresses issues of incomplete recovery and patient compliance through its innovative digital therapy solutions, which are both cost-effective and convenient. The company has developed KIMIA, the world's first continuous knee health monitor, combined with an AI-based digital therapist that facilitates access to therapy. Kinexcs collaborates with key opinion leaders and major public hospitals in Singapore on various clinical projects, while also offering its products through orthopedic surgeons and significant implant manufacturers. The integration of continuous monitoring and real-time exercise guidance supports patients in managing their conditions effectively.
Japet
Seed Round in 2017
Japet Medical Devices is a French biomedical company focused on developing innovative robotic equipment aimed at enhancing treatment quality. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to assist with both occupational and daily health needs. These exoskeletons are designed to restore balance and facilitate free movement, offering pain relief through orthotic support. Japet's commitment to creating user-friendly solutions reflects its belief in the transformative potential of these technologies to improve the quality of life for many individuals.
ZiO Health
Convertible Note in 2017
ZiO Health is a biotechnology company that focuses on transforming laboratory testing through its proprietary pocket-sized technology, which allows for point-of-care diagnostics. By combining advanced biosensor technology with machine learning algorithms, ZiO Health provides real-time testing results tailored to each patient's unique profile. This innovative approach enables users to measure, test, and detect the molecular composition of various substances, facilitating personalized health insights. The company's devices aim to optimize health management and enhance patient outcomes, allowing individuals to conduct quality home diagnostics and take proactive steps in preventing illness.
nura
Seed Round in 2017
The nuraphone is a new headphone that integrates unique technology to automatically measure your hearing (from the outer ear all the way to the brain) and adapt music perfectly to you. In order for headphones to deliver the right sound, they must be matched to the listener. Nuraphones even recognize you when you put them on.
Elephant Robotics
Convertible Note in 2016
Elephant Robotics specializes in the development of cooperative robots designed to assist users with repetitive tasks across various industries, including medical, education, agriculture, scientific research, and transportation. Their robots feature integrated arm, voice, and vision systems, which facilitate applications such as pick and place, packaging, and testing. By offering user-friendly automation solutions, Elephant Robotics enables businesses to enhance productivity while ensuring a safe working environment and reducing production costs. The company is recognized for providing innovative, OS-based applications and intelligent manufacturing services, aiming to improve daily life through the integration of advanced robotic technology.
Criam
Convertible Note in 2016
Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.
Japet
Convertible Note in 2016
Japet Medical Devices is a French biomedical company focused on developing innovative robotic equipment aimed at enhancing treatment quality. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to assist with both occupational and daily health needs. These exoskeletons are designed to restore balance and facilitate free movement, offering pain relief through orthotic support. Japet's commitment to creating user-friendly solutions reflects its belief in the transformative potential of these technologies to improve the quality of life for many individuals.
Criam
Seed Round in 2016
Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.
Elephant Robotics
Seed Round in 2016
Elephant Robotics specializes in the development of cooperative robots designed to assist users with repetitive tasks across various industries, including medical, education, agriculture, scientific research, and transportation. Their robots feature integrated arm, voice, and vision systems, which facilitate applications such as pick and place, packaging, and testing. By offering user-friendly automation solutions, Elephant Robotics enables businesses to enhance productivity while ensuring a safe working environment and reducing production costs. The company is recognized for providing innovative, OS-based applications and intelligent manufacturing services, aiming to improve daily life through the integration of advanced robotic technology.
Japet
Seed Round in 2016
Japet Medical Devices is a French biomedical company focused on developing innovative robotic equipment aimed at enhancing treatment quality. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to assist with both occupational and daily health needs. These exoskeletons are designed to restore balance and facilitate free movement, offering pain relief through orthotic support. Japet's commitment to creating user-friendly solutions reflects its belief in the transformative potential of these technologies to improve the quality of life for many individuals.
nura
Seed Round in 2016
The nuraphone is a new headphone that integrates unique technology to automatically measure your hearing (from the outer ear all the way to the brain) and adapt music perfectly to you. In order for headphones to deliver the right sound, they must be matched to the listener. Nuraphones even recognize you when you put them on.
Feel Therapeutics
Seed Round in 2016
Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.
FeetMe
Seed Round in 2015
FeetMe is a digital health company specializing in advanced technology for gait and activity assessments in both clinical and real-world settings. The company develops innovative wearable products, particularly smart insoles equipped with pressure sensors and motion analysis algorithms. These products enable real-time monitoring of patients' mobility and posture, facilitating comprehensive evaluations of movement disorders and mobility constraints. By providing relevant digital biomarkers, FeetMe aims to support clinical research and enhance patient care, allowing healthcare professionals to track disease progression, improve functional outcomes, and optimize treatment strategies.
Kokoon Technology
Seed Round in 2015
Kokoon Technology Limited is a digital health company based in London, United Kingdom, specializing in sleep enhancement solutions. Founded in 2013, the company manufactures sleep sensing headphones that incorporate EEG brainwave sensing technology to monitor sleep patterns. These headphones feature active noise cancellation, noise isolation, and white noise capabilities for improved sleep quality. Additionally, Kokoon offers a mobile application that includes an audio relaxation library and sleep analysis tools, utilizing movement and EEG sensors to gain insights into individual sleep behaviors. By combining advances in sensor technology and data science, Kokoon aims to personalize and enhance the sleep experience for users.
Lief Therapeutics
Seed Round in 2015
Lief Therapeutics is a medical device company focused on improving at-home care for individuals suffering from post-traumatic stress disorder, depression, and anxiety. The company has developed a discreet biosensing patch that measures heart rate and breathing patterns with medical accuracy. This wearable device, known as Lief, helps users manage their stress responses through biofeedback exercises, allowing them to monitor their emotions and behaviors in real-time. Additionally, the device provides clinicians with insights into patient progress, enabling in-session training and tracking of psychological assessments. Lief Therapeutics also offers the Lief Health Score application, which records thoughts, emotions, and sensations, facilitating the tracking of daily progress and personalized practice exercises. Founded in 2014 and based in San Francisco, California, the company sells its products online.
Babybe
Pre Seed Round in 2014
Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
Darma
Pre Seed Round in 2014
Darma Inc. specializes in non-wearable health tracking technology, offering a unique DARMA cushion that allows users to monitor their vital signs through a dedicated application. This innovative cushion tracks stress levels, sitting time, and posture, providing reminders to encourage users to stand and move. Additionally, it alerts users to high stress levels and suggests guided meditation for stress management. Beyond the DARMA cushion, the company has developed a 2mm fiber optic sensor pad designed for placement under mattresses in hospitals or homes, enabling continuous and non-invasive monitoring of vital signs and cardiac performance. This integrated system aims to enhance proactive health management, reduce hospital readmissions, and improve the quality of life for patients with chronic diseases by utilizing advanced algorithms and machine learning to predict and prevent adverse health events.
Babybe
Seed Round in 2013
Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
foc.us
Pre Seed Round in 2013
foc.us develops a transcranial Direct Current Stimulation (tDCS) headset aimed at enhancing cognitive performance, particularly for gamers. This technology delivers a mild electrical current to the brain, stimulating the neocortex to improve focus and brain plasticity, which can potentially lead to quicker synaptic firing. In addition to its applications in gaming, the company's platform is designed to explore the effects of stimulation on the brain, with potential implications for treating various medical conditions. By leveraging advancements in brain research, foc.us seeks to provide users with tools to enhance concentration and cognitive abilities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.